PVI
AGRX

Pura Vida Investments’s Agile Therapeutics AGRX Stock Holding History

Pura Vida Investments’s Portfolio AGRX Stock Details AGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-37
Closed -$112K – 135
2019
Q1 		$112K Buy
+37
New +$78.4K 0.02% 103
2017
Q4 		– Sell
-145
Closed -$1.29M – 103
2017
Q3 		$1.29M Buy
145
+58
+67% +$445K 0.38% 64
2017
Q2 		$654K Buy
87
+5
+6% +$34.6K 0.26% 56
2017
Q1 		$527K Hold
82
– – 0.16% 69
2016
Q4 		$938K Buy
82
+70
+583% +$981K 0.34% 53
2016
Q3 		$174K Buy
+12
New +$171K 0.05% 85

Other funds holding AGRX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Pura Vida Investments's AGRX Position: Q2 2019 in Review

Pura Vida Investments sold out of Agile Therapeutics (AGRX) in Q2 2019, closing a stake of 37 shares — an estimated $112K sold.

Pura Vida Investments first reported a position in AGRX in Q3 2016 and held it in 6 quarters. The position peaked at $1.29M in Q3 2017. 24 funds tracked by Wall St. Rank hold AGRX as of Q2 2019.

  • Pura Vida Investments reported no remaining Agile Therapeutics position as of Q2 2019 after selling out during the quarter.
  • Pura Vida Investments sold 37 Agile Therapeutics shares in Q2 2019, an estimated $112K.
  • Pura Vida Investments first reported a position in Agile Therapeutics in Q3 2016 and held it in 6 quarters.
  • Pura Vida Investments's Agile Therapeutics position peaked at $1.29M in Q3 2017.
  • 24 funds tracked by Wall St. Rank held Agile Therapeutics as of Q2 2019.

Based on Pura Vida Investments's 13F filing for Q2 2019, filed 14 Aug 2019.